Literature DB >> 17268422

Consumption of trans fats and estimated effects on coronary heart disease in Iran.

D Mozaffarian1, M Abdollahi, H Campos, A Houshiarrad, W C Willett.   

Abstract

OBJECTIVE: To investigate the consumption of industrial trans-fatty acids (TFAs) in Iranian homes and the proportion of coronary heart disease (CHD) events in Iran attributable to such intake. DESIGN, SETTING AND PARTICIPANTS: The consumption of industrial TFAs was determined using (1) detailed in-home assessments of dietary intake among 7158 urban and rural households containing 35 924 individuals and (2) gas chromatography to determine TFA contents of the most commonly consumed partially hydrogenated oils. The population-attributable risk for CHD owing to TFA consumption was calculated on the basis of (1) documented effects of TFAs on total:high-density lipoprotein (HDL) cholesterol in randomized controlled dietary trials and (2) relationships of TFA intake with incidence of CHD in prospective observational studies.
RESULTS: Partially hydrogenated oils were used extensively for cooking in Iranian homes with average per-person intake of 14 g/1000 kcal. TFAs accounted for 33% of fatty acids in these products, or 4.2% of all calories consumed (12.3 g/day). On the basis of total:HDL cholesterol effects alone, 9% of CHD events would be prevented by replacement of TFA in Iranian homes with cis-unsaturated fats (8% by replacement with saturated fats). On the basis of relationships of TFA intake with CHD incidence in prospective studies, 39% of CHD events would be prevented by replacement of TFA with cis-unsaturated fats (31% by replacement with saturated fats). These population-attributable risks may be overestimates owing to competing risks and because not all the fat used for cooking might actually be consumed. If actual TFA consumption were only half as large, the estimated proportion of CHD events prevented by TFA elimination would be 5% on the basis of total:HDL cholesterol effects and replacement with cis-unsaturated (4% for replacement with saturated fats), and 22% on the basis of prospective studies and replacement with cis-unsaturated fats (17% for replacement with saturated fats). These estimates do not include possible additional benefits derived from replacing TFAs with vegetable oils containing n-3 fatty acids.
CONCLUSIONS: Intake of TFAs is high in Iranian homes and contributes to a sizeable proportion of CHD events. Replacement of partially hydrogenated oils with unhydrogenated oils would likely produce substantial reductions in CHD incidence. SPONSORSHIP: National Heart, Lung and Blood Institute, National Institutes of Health, USA. National Nutrition & Food Technology Research Institute, Tehran, Iran.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268422     DOI: 10.1038/sj.ejcn.1602608

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  38 in total

1.  Nutritional related cardiovascular risk factors in patients with coronary artery disease in Iran: a case-control study.

Authors:  Reza Amani; Mohammad Noorizadeh; Samira Rahmanian; Naser Afzali; Mohammad H Haghighizadeh
Journal:  Nutr J       Date:  2010-12-26       Impact factor: 3.271

2.  Ethnic Variation in Lipid Profile and Its Associations with Body Composition and Diet: Differences Between Iranians, Indians and Caucasians Living in Australia.

Authors:  Majid Meshkini; Fariba Alaei-Shahmiri; Cyril Mamotte; Jaya Earnest
Journal:  J Immigr Minor Health       Date:  2017-02

3.  Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.

Authors:  Rafael Longhi; Roberto Farina Almeida; Letiane Machado; Maria Marta Medeiros Frescura Duarte; Débora Guerini Souza; Priscila Machado; Adriano Martimbianco de Assis; André Quincozes-Santos; Diogo Onofre Souza
Journal:  Eur J Nutr       Date:  2016-01-11       Impact factor: 5.614

4.  Effects of partially hydrogenated, semi-saturated, and high oleate vegetable oils on inflammatory markers and lipids.

Authors:  Kim-Tiu Teng; Phooi-Tee Voon; Hwee-Ming Cheng; Kalanithi Nesaretnam
Journal:  Lipids       Date:  2010-05-01       Impact factor: 1.880

5.  Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study.

Authors:  Renata Micha; Irena B King; Rozenn N Lemaitre; Eric B Rimm; Frank Sacks; Xiaoling Song; David S Siscovick; Dariush Mozaffarian
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

Review 6.  Scaling up chronic disease prevention interventions in lower- and middle-income countries.

Authors:  Thomas A Gaziano; Neha Pagidipati
Journal:  Annu Rev Public Health       Date:  2013-01-07       Impact factor: 21.981

7.  The global availability of n-3 fatty acids.

Authors:  Stefka Petrova; Plamen Dimitrov; Walter C Willett; Hannia Campos
Journal:  Public Health Nutr       Date:  2011-03-31       Impact factor: 4.022

Review 8.  Trans fatty acids: effects on cardiometabolic health and implications for policy.

Authors:  R Micha; D Mozaffarian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-11-08       Impact factor: 4.006

Review 9.  Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes.

Authors:  Renata Micha; Dariush Mozaffarian
Journal:  Nat Rev Endocrinol       Date:  2009-04-28       Impact factor: 43.330

Review 10.  Trans-fatty acids and nonlipid risk factors.

Authors:  Sarah K Wallace; Dariush Mozaffarian
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.